Projects

• Using drugs to treat peripheral occlusive arterial diseases;
  cost-effectiveness analysis
  
• Ramipril treatment; economic evaluation based on the AIRE Study
  
• Hepatic encephalopathy;
  consulting project to develop a research-protocol for the clinical trial of a drug
  
• Cardiac insufficiency; economic evaluation of beta blocker treatment
  
• Treating diabetic polyneuropathy with benfotiamin; cost-effectiveness analysis
• Prophylaxis and therapy of opportunistic mycotic infections in immunosuppressed patients; cost-effectiveness analysis
  
• Secondary prevention of a re-infarction with low-dosage acetylsalicylic acid;
  cost-effectiveness analysis
• Alcoholism in Germany;
  cost-of-illness study
• Alcoholism in Europe;
  mortality-related cost-of-illness study
• Recommendations for pharmacoeconomical studies in Germany;
  advising the Working Group "Pharmacoeconomics" of the German Association for Clinical Pharmacology and Therapy
• Ramipril treatment; economic evaluation based on the REIN Study
  
• Prevention of relapses in treatment of alcoholism; cost-effectiveness study
• Specific immunotherapy versus symptomatic treatment of allergic rhinitis; cost-effectiveness analysis
• Treatment of polyneuropathy with benfotiamin; cost-effectiveness analysis
• The burden of illness incurred by senile dementia in Germany; cost-of-illness study
• Antibiotic treatment with levofloxacin; cost-effectiveness analysis
• The burden of illness incurred by osteoporosis in Germany; cost-of-illness study
• Ramipril treatment; economic evaluation based on the HOPE Study
• Sequential treatment of rheumatoid arthritis; cost-effectiveness analysis
• Cost effectiveness and cost utility of osteoporosis treatment in Germany; cost-effectiveness analysis, cost-utility analysis
• Treatment costs of venous thromboembolic complications in acutely ill medical inpatients in Germany; cost-of-illness study
• Burden of illness imposed by venous thromboembolism as an original disease in Germany; cost-of-illness study
• Prophylaxis of venous thromboembolic complications in acutely ill medical inpatients; cost-effectiveness analysis from the perspective of German hospitals
• Development of software tools for the hospital-specific calculation of cost-minimization analyses; VBA-based programming
• Interactive modelling of cost-consequence, cost-effectiveness and cost-utility analyses on a VBA-based platform; computer application in health economics